Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine Ryan, M.D.

Concepts (129)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Lymphocytic, Chronic, B-Cell8202315962.060 Why?
Lymphoma, Large B-Cell, Diffuse3202313781.020 Why?
Lymphoma, Mantle-Cell120232330.760 Why?
Pneumocystis carinii12020740.700 Why?
Neurotoxicity Syndromes120232900.690 Why?
Pneumonia, Pneumocystis120202490.650 Why?
Opportunistic Infections120203890.580 Why?
Proto-Oncogene Proteins c-bcl-22202314340.460 Why?
Protein Kinase Inhibitors4202055350.330 Why?
Antigens, CD19220233800.280 Why?
Pyrazoles1201619720.280 Why?
Neoplasm, Residual220229730.250 Why?
Immunotherapy, Adoptive2202312700.250 Why?
Antineoplastic Combined Chemotherapy Protocols72023115240.250 Why?
Hematopoietic Stem Cell Transplantation4201654420.240 Why?
Pyrimidines1201629420.240 Why?
Antineoplastic Agents32023136950.210 Why?
Piperidines2202316020.200 Why?
Isoantibodies220156790.200 Why?
H-Y Antigen22015450.170 Why?
Graft vs Host Disease3201629570.170 Why?
Clinical Trials, Phase III as Topic120228410.160 Why?
Recurrence2202383400.160 Why?
Retreatment120196100.150 Why?
Cardiology Service, Hospital120192460.150 Why?
Multicenter Studies as Topic1202216770.150 Why?
Cyclophosphamide1202322420.140 Why?
Staurosporine320122510.140 Why?
Tissue Donors2201622400.140 Why?
Central Nervous System1202313570.130 Why?
Chimerism120161580.130 Why?
Molecular Targeted Therapy2201927270.120 Why?
Lymphocyte Depletion120166080.120 Why?
Receptors, Antigen, T-Cell1202325400.120 Why?
Germinal Center120163770.120 Why?
Receptors, Antigen12013530.120 Why?
Drug Resistance, Neoplasm3202351720.120 Why?
Lymphoma, B-Cell120199310.110 Why?
Immunomodulation120165410.110 Why?
Withholding Treatment120165990.100 Why?
Treatment Outcome62023631140.100 Why?
Patient Admission1201913800.100 Why?
Th2 Cells1201610610.100 Why?
Adenine120169360.100 Why?
Transplantation, Homologous2201647760.100 Why?
Humans1820237443430.090 Why?
Urea120124500.090 Why?
Academic Medical Centers1201927590.080 Why?
Prospective Studies22023532880.080 Why?
Thiophenes120125880.070 Why?
T-Lymphocytes22023101800.070 Why?
Randomized Controlled Trials as Topic1202299590.070 Why?
Lymph Nodes1201634740.060 Why?
Protein Kinases1201216400.060 Why?
Camptothecin320125760.060 Why?
Healthcare Disparities1201931580.060 Why?
B-Lymphocytes1201646650.060 Why?
Neoplasms32021216830.050 Why?
Coronavirus Infections1202031330.050 Why?
Health Services Accessibility1201951370.050 Why?
Pneumonia, Viral1202032400.050 Why?
bcl-X Protein120234110.050 Why?
Tumor Suppressor Protein p531201229480.050 Why?
Adult720232140550.050 Why?
Hematopoietic Stem Cells1201333860.050 Why?
Genes, p53220127550.040 Why?
Neoplasm Proteins1201237030.040 Why?
Apoptosis Regulatory Proteins1202311570.040 Why?
Immunization, Passive120206230.040 Why?
Retrospective Studies22023774490.040 Why?
Heart Failure12019109000.030 Why?
Aged620201632800.030 Why?
Middle Aged720202133830.030 Why?
Breast Neoplasms22012208220.030 Why?
Cohort Studies12016405610.030 Why?
Gene Order120131760.030 Why?
Ribosomal Protein S612012700.030 Why?
Apoptosis2202397270.030 Why?
Cell Line, Tumor22023166890.030 Why?
Genes, cdc120121160.030 Why?
Female820203801940.030 Why?
Genes, erbB-2120121620.030 Why?
Lentivirus120135010.020 Why?
Anti-Inflammatory Agents1202017900.020 Why?
Male620203501180.020 Why?
Transduction, Genetic120139130.020 Why?
Cytotoxicity, Immunologic1201313690.020 Why?
Myeloid Cells120138100.020 Why?
Antineoplastic Agents, Phytogenic120126240.020 Why?
Maximum Tolerated Dose120108920.020 Why?
Antiviral Agents1202029870.020 Why?
Inpatients1201925180.020 Why?
Health Status Disparities1201917970.020 Why?
Survival Analysis12020102520.020 Why?
Mice, Inbred NOD1201218780.020 Why?
Receptors, Progesterone1201210970.020 Why?
Boston1201993130.020 Why?
DNA, Neoplasm1201217580.020 Why?
Mice, SCID1201227160.020 Why?
RNA, Messenger12021130330.020 Why?
Leukocytes, Mononuclear1201218360.020 Why?
Time Factors22019400750.020 Why?
Patient Readmission1201931140.020 Why?
Aged, 80 and over22020577760.020 Why?
Killer Cells, Natural1201321330.020 Why?
Xenograft Model Antitumor Assays1201235570.010 Why?
Receptors, Estrogen1201221870.010 Why?
Genetic Vectors1201334200.010 Why?
Cell Cycle1201229670.010 Why?
Anemia1201215060.010 Why?
Flow Cytometry1201359740.010 Why?
Lymphocyte Activation1201355240.010 Why?
DNA Damage1201224320.010 Why?
Mice22023811830.010 Why?
Proteomics1201536380.010 Why?
Animals320231687570.010 Why?
Mice, Transgenic1201397340.010 Why?
Pandemics1202083880.010 Why?
Cell Line12013159970.010 Why?
Risk Assessment12019233380.010 Why?
Age Factors12015183700.010 Why?
Immunotherapy1201344450.010 Why?
Cell Differentiation12013114830.010 Why?
Disease Models, Animal12013180290.010 Why?
Prognosis12015290630.010 Why?
Risk Factors12019722900.010 Why?
Mutation12012297860.000 Why?
Adolescent12015857810.000 Why?
Young Adult12010564300.000 Why?
Ryan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Co-Authors (87)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.